Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Q/C Technologies, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- 0 vs. Q4 2025
- Shares held
- 627.6K
- −72.1K (−10.3%) vs. Q4 2025
- Total value
- $2.16M
- −$626.8K (−22.5%) vs. Q4 2025
- New holders
- 7
- 5 more added
- Sold out
- 7
- 1 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QCLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $2.87M |
| Q1 2026 | 18 | $2.16M |
| Q4 2025 | 19 | $3.00M |
| Q3 2025 | 12 | $69.8K |
| Q2 2025 | 33 | $65.3K |
| Q1 2025 | 24 | $69.0K |
| Q4 2024 | 25 | $145.8K |
| Q3 2024 | 20 | $60.3K |
| Q2 2024 | 23 | $114.6K |
| Q1 2024 | 20 | $1.38M |
| Q4 2023 | 50 | $1.64M |
| Q3 2023 | 51 | $2.52M |
| Q2 2023 | 48 | $6.51M |
| Q1 2023 | 50 | $6.98M |
| Q4 2022 | 43 | $4.49M |
| Q3 2022 | 43 | $9.94M |
| Q2 2022 | 39 | $10.3M |
| Q1 2022 | 35 | $22.4M |
| Q4 2021 | 41 | $27.1M |
| Q3 2021 | 28 | $41.8M |
| Q2 2021 | 23 | $30.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Q/C Technologies, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quinn Opportunity Partners LLC | 211,390 | $729.3K | 0.04% | 00.0% | Unchanged |
| Jane Street Group, LLC | 126,188 | $435.3K | 0.00% | +85,702+211.7% | Added |
| UBS Group AG | 77,989 | $269.1K | 0.00% | +60,564+347.6% | Added |
| ADAR1 Capital Management, LLC | 50,000 | $172.5K | 0.01% | +50,000 | New |
| Geode Capital Management, LLC | 47,390 | $163.5K | 0.00% | +18,138+62.0% | Added |
| Vanguard Capital Management LLC | 37,511 | $129.4K | 0.00% | +37,511 | New |
| HRT Financial LP | 22,404 | $77.0K | 0.00% | +22,404 | New |
| Dimensional Fund Advisors LP | 19,058 | $65.8K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 15,555 | $53.7K | 0.00% | +15,555 | New |
| State Street Corp | 12,905 | $44.5K | 0.00% | +12,905 | New |
| Pin Oak Investment Advisors Inc | 3,500 | $12.0K | 0.01% | +3,500 | New |
| Sunbelt Securities, Inc. | 1,750 | $6.04K | 0.00% | +1,750 | New |
| Tower Research Capital LLC (TRC) | 1,593 | $5.50K | 0.00% | +1,358+577.9% | Added |
| BNP Paribas Arbitrage, SA | 300 | $1.03K | 0.00% | −900−75.0% | Reduced |
| BlackRock, Inc. | 19 | $66 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 2 | $7 | 0.00% | 00.0% | Unchanged |
| Bryn Mawr Trust Co | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 6 | $0 | 0.00% | +2+50.0% | Added |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −333,826−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −35,380−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −11,333−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |